Type 2 Diabetes

Canagliflozin appears to offer significant benefits when used in conjunction with insulin therapy.

The patient, a woman, 52 years of age, has type 2 diabetes and is on metformin, a GLP-1 agonist, and a long-acting insulin. Over the past few months, I’ve received calls and emails from her every now and then to let me know her glucose levels were rising, but whenever …

A male patient, 56 years of age, with type 2 diabetes, hypertension, congestive heart failure, and sleep apnea visited. We hadn’t seen him for 6 months. His blood pressure was up, in the 140-160/90–102 range, glucose levels were higher than his targets, he was gaining weight, and continually complaining of …

A low CD34+ count also diminished the protective effects of ACE inhibitors/ARBs on microalbuminuria progression… Low circulating progenitor cells have been shown to predict future cardiovascular events and mortality in patients with CKD and low levels in diabetic patients may indicate microvascular complications. Diabetes lowers the levels of circulating and …

A large, population-based, observational study identified different profiles of inflammatory and immune biomarkers in people with no diabetes, prediabetes, or type 2 diabetes… Findings revealed an increase in the median concentrations of white blood cells, monocytes, granulocytes, interleukin-18, IL-1 receptor antagonist and fibrinogen in patients with diabetes and prediabetes compared …

University of Missouri researchers find eating breakfast increases release of insulin after lunch… Individuals with type 2 diabetes have difficulty regulating their glucose — or blood sugar — levels, particularly after meals. This research can help in preventing the spikes. According to Jill Kanaley, professor and associate chair in the …

According to a new study, statin therapy may increase the risk of type 2 diabetes by decreasing insulin sensitivity and secretion… Statins are considered to be safe and well-tolerated medications commonly used for the prevention of cardiovascular disease (CVD) events in individuals with and without diabetes. However, recent studies showed …

But vaccine still recommended for diabetes patients due to increased risk of disease… Information presented at the Annual Conference on Vaccine Research states there is no statistical evidence that type 2 diabetes affects the hepatitis B vaccine (HBV). The committee also added that patients aged 19 to 59 who are …

DR prevalence of DR higher in T1s; T2s have the major burden…. One of the microvascular complications of type 1 and type 2 diabetes is diabetic retinopathy (DR), which can cause blindness and low vision in this patient population along with other age-related eyes condition. Many screening programs have been …

New treatment strategies have focused on both dipeptidyl peptidase (DPP)-4 inhibitors, and SGLT-2’s.